Table 1.
Baseline characteristics of 90 patients
| Variable | Value |
|---|---|
| Age, yr | 60(49–66.25) |
| Male,n | 57 (63.33%) |
| Body mass index, kg/m2 | 25.56(22.65–28.67) |
| Systolic blood pressure, mmHg | 127 ± 15 |
| Smoking status | |
| Never | 28(31.11%) |
| Past | 30(33.33%) |
| Current | 32(35.56%) |
| Drinking status, standard drinks/wk | |
| Never | 65(72.22%) |
| 1–4 | 10(11.11%) |
| 5–8 | 11(12.22%) |
| >8 | 4(4.44%) |
| Basic diseases | |
| coronary heart disease | 55(61.11%) |
| hypertension | 44(48.89%) |
| diabetes | 13(14.44%) |
| hyperuricemia | 45(50%) |
| Laboratory results | |
| White blood cells, ×109/L | 6.86 ± 2.19 |
| Neutrophilicgranulocyte,% | 58.79 ± 12.89 |
| Hemoglobin, ×1012/L | 142(131–150.25) |
| Platelets, ×109/L | 216(174.75–258) |
| blood urea nitrogen,mmol/L | 5.1(4.2–5.95) |
| Creatinine,umol/L | 68.87(60–77) |
| uric acid,umol/L | 389(306–438.1) |
| Glucose, mmol/L | 4.86(4.32–5.77) |
| Total cholesterol, mmol/L | 3.77(3.08–4.54) |
| Triglyceride, mmol/L | 1.52(1.17–2.35) |
| high density lipoprotein,mmol/L | 140.54 ± 18.14 |
| total bilirubin,umol/L | 11.3(8.6–14.2) |
| γ-glutamyl transpeptadase,U/L | 25.5(18–39.25) |
Data are presented as median (interquartile range), mean±SD, or number (%).